A randomized psychiatric intervention in complex somatic patients identified by means of the INTERMED

Détails

ID Serval
serval:BIB_09037C1ABB52
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Abstract (résumé de présentation): article court qui reprend les éléments essentiels présentés à l'occasion d'une conférence scientifique dans un poster ou lors d'une intervention orale.
Collection
Publications
Titre
A randomized psychiatric intervention in complex somatic patients identified by means of the INTERMED
Auteur(s)
Bel Hadj Fatima, Zdrojewski C., Jonge Peter de, Miéville Jean-Christophe, Krenz Sonia, So Alexander, Ruiz Juan, Stiefel Friedrich
ISBN
0937-2032
Statut éditorial
Publié
Date de publication
2007
Peer-reviewed
Oui
Volume
57
Série
Psychotherapie, Psychosomatik, medizinische Psychologie
Pages
80
Langue
anglais
Notes
SAPHIRID:61394
Résumé
A considerable proportion of patients admitted to a general hospital are complex patients suffering from psychosocial co-morbidities. Epidemiological studies have demonstrated a close relationship between psychosocial co-morbidity, health care utilization and medical and psychological outcomes.
This study evaluates a psychiatric intervention targeted on complex patients identified by means of the INTERMED, a case-finder for case complexity [1,2].
Methods: Complex patients are identified with the INTERMED in a rheumatology inpatient clinic and a diabetes outpatient unit. INTERMED provides a valid and reliable bio-psycho-social assessment [1,2]; patients with cut-off scores >20 being identified as complex [3] are included and randomized into "care as usual" or intervention groups. The intervention consists of (i) a multidisciplinary team conference or (ii) one or more psychiatry and/or liaison nurse consultations. Follow up is scheduled every three months for a year and assesses quality of life, anxiety and depression, medical outcome and health care utilization [4].
Results: After 3 years study period, 893 patients have been approached and 247 patients have been included. After analyses, we can see that major depression reduce from 61% to 28% in the intervention group and remained the stable in care as usual. Compared to care as usual, a significant improvement over time of depressive symptoms was also observed for the intervention group. In addition, hospital admission occurred less often in the latter, reaching statistical significance for the period between 6 and 9 months follow up. The documented baseline and at least follow up levels of HbA1c of only 28 patients did not allow a meaningful statistical analysis.
Discussion: Discussion will focus on a description of the sample, an analysis of correlations between INTERMED scores and the different objective and subjective baseline measures and final results of outcome.
Création de la notice
10/03/2008 10:27
Dernière modification de la notice
20/08/2019 12:31
Données d'usage